Latest Breaking News On - தாமஸ் ஜாக்கி - Page 1 : comparemela.com
Lancaster University: Launch of UNITE4TB partnership marks a new era in Tuberculosis treatment development
indiaeducationdiary.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiaeducationdiary.in Daily Mail and Mail on Sunday newspapers.
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Date Time
£1.7m project to explore groundbreaking new treatment for biofilm infections in foot ulcers
A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating – and potentially deadly – wound infections launches today.
The groundbreaking Plasma-activated Antimicrobial Hydrogel Therapy (PAHT) would provide a new treatment modality for biofilm infections in diabetic foot ulcers (DFUs), a type of wound which make up around 10 per cent of the 2.2m wounds reported annually in the UK.
More than a third of the +4.5m diabetics in the UK have a lifetime risk of foot ulcers, of which 50 per cent become infected. Around 10 per cent of these patients then require lower limb amputation due to tissue and bone infection. The prognosis for these patients is bleak; 44 per cent usually die within five years.
Groundbreaking therapy may provide a new treatment modality for biofilm infections in foot ulcers
A new £1.7m project to explore using plasma jets and antimicrobial dressings to treat debilitating - and potentially deadly - wound infections launches today.
The groundbreaking Plasma-activated Antimicrobial Hydrogel Therapy (PAHT) would provide a new treatment modality for biofilm infections in diabetic foot ulcers (DFUs), a type of wound which make up around 10 per cent of the 2.2m wounds reported annually in the UK.
More than a third of the +4.5m diabetics in the UK have a lifetime risk of foot ulcers, of which 50 per cent become infected. Around 10 per cent of these patients then require lower limb amputation due to tissue and bone infection. The prognosis for these patients is bleak; 44 per cent usually die within five years.